Radiation with cisplatin or carboplatin for locally advanced cervix cancer: The experience of a tertiary cancer centre

Definitive treatment with concurrent cisplatin and radiation is the standard of care for locally advanced cervix cancer. The optimal management of patients with a contraindication to cisplatin has not been established. We conducted a retrospective audit of concurrent chemotherapy in a cohort of patients with locally advanced cervix cancer.

[1]  Kanyarat Katanyoo,et al.  Treatment outcomes of concurrent weekly carboplatin with radiation therapy in locally advanced cervical cancer patients. , 2011, Gynecologic oncology.

[2]  H. Yoshikawa,et al.  A phase III trial of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in stage IVB, persistent or recurrent cervical cancer: Gynecologic Cancer Study Group/Japan Clinical Oncology Group Study (JCOG0505). , 2010, Japanese journal of clinical oncology.

[3]  E. Domingo,et al.  Capecitabine-based chemoradiotherapy with adjuvant capecitabine for locally advanced squamous carcinoma of the uterine cervix: phase II results. , 2009, The oncologist.

[4]  L. Barbera,et al.  Management of early and locally advanced cervical cancer. , 2009, Seminars in oncology.

[5]  R. Fisher,et al.  Patterns of Failure and Prognostic Factor Analyses in Locally Advanced Cervical Cancer Patients Staged by Positron Emission Tomography and Treated With Curative Intent , 2009, International Journal of Gynecologic Cancer.

[6]  D. Alberts,et al.  Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  R. Colomer,et al.  Novel chemotherapy approaches in chemoradiation protocols. , 2008, Gynecologic oncology.

[8]  L. Downs,et al.  The disparity of cervical cancer in diverse populations. , 2008, Gynecologic oncology.

[9]  T. Herzog,et al.  A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer. , 2007, Gynecologic oncology.

[10]  C. Khorprasert,et al.  A randomized phase III trial of concurrent chemoradiotherapy in locally advanced cervical cancer: preliminary results. , 2007, Gynecologic oncology.

[11]  Farin Kamangar,et al.  Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  P. Maisonneuve,et al.  Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[13]  B. Monk,et al.  Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  B. Monk,et al.  Gynecologic oncology group trials of chemotherapy for metastatic and recurrent cervical cancer , 2005, Current oncology reports.

[15]  A. Tinker,et al.  Carboplatin and paclitaxel for advanced and recurrent cervical carcinoma: the British Columbia Cancer Agency experience. , 2005, Gynecologic Oncology.

[16]  P. Rose,et al.  Evaluation of concurrent and adjuvant carboplatin with radiation therapy for locally advanced cervical cancer. , 2004, Gynecologic oncology.

[17]  A. Dueñas-González,et al.  A phase I study of carboplatin concurrent with radiation in FIGO stage IIIB cervix uteri carcinoma. , 2003, International journal of radiation oncology, biology, physics.

[18]  R. Higgins,et al.  Concurrent carboplatin with pelvic radiation therapy in the primary treatment of cervix cancer. , 2003, Gynecologic Oncology.

[19]  P. Grigsby,et al.  Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  B N Bundy,et al.  Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  B N Bundy,et al.  Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. , 1999, The New England journal of medicine.

[22]  P J Eifel,et al.  Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. , 1999, The New England journal of medicine.

[23]  A. Adjei,et al.  Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  K. Blank,et al.  Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer , 1999 .

[25]  E. Sartori,et al.  Continuous infusion of carboplatin during conventional radiotherapy treatment in advanced squamous carcinoma of the cervix uteri IIB-IIIB (UICC). A phase I/II and pharmacokinetic study. , 1997, American journal of clinical oncology.

[26]  S. Formenti,et al.  Carboplatin as a radiation sensitizer in locally advanced cervical cancer: a pilot study. , 1997, Gynecologic oncology.

[27]  R. Crooijmans,et al.  Effectiveness in inhibition of recovery of cell survival by cisplatin and carboplatin: influence of treatment sequence. , 1991, International journal of radiation oncology, biology, physics.

[28]  P. Disaia,et al.  A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  K. Fu.  Biological basis for the interaction of chemotherapeutic agents and radiation therapy , 1985, Cancer.

[30]  L. Lagasse,et al.  Cis‐platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: A phase ii study of the gynecologic oncology group , 1981, Cancer.

[31]  R. Gori.  [Carcinoma of the cervix uteri]. , 1970, Prensa medica argentina.